10x Genomics Inc. (TXG)
NASDAQ · Healthcare
10x Genomics Inc. annual/quarterly total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- 10x Genomics Inc. total liabilities for the quarter ending December 31, 2025 were 245.0M, a 17.52% increase year-over-year.
- 10x Genomics Inc. total liabilities for 2025 were 245.0M, a 17.52% increase from 2024.
- 10x Genomics Inc. total liabilities for 2024 were 208.5M, a 6.96% decrease from 2023.
- 10x Genomics Inc. total liabilities for 2023 were 224.1M, a 0.39% increase from 2022.
- 10x Genomics Inc. total liabilities for 2022 were 223.2M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| 10x Genomics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $245 |
| 2024 | $209 |
| 2023 | $224 |
| 2022 | $223 |
| 2021 | $201 |
| 2020 | $190 |
| 2019 | $186 |
| 2018 | $101 |
| 10x Genomics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $245 |
| 2024-12-31 | $209 |
| 2023-12-31 | $224 |
| 2022-12-31 | $223 |
| 2021-12-31 | $201 |
| 2020-12-31 | $190 |
| 2019-12-31 | $186 |
| 2018-12-31 | $101 |
10x Genomics Inc. Total Liabilities — FAQ
10x Genomics Inc. (TXG) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TXG's total liabilities history?
The chart and table above show 10x Genomics Inc.'s total liabilities by year and by quarter, including the growth rate.